18 results
10-Q
2023 Q2
EX-3.1
TXMD
TherapeuticsMD Inc
Quarterly report
14 Aug 23
7:30am
8-K
EX-3.1
TXMD
TherapeuticsMD Inc
6 Jul 23
Unregistered Sales of Equity Securities
4:38pm
8-K
EX-3.2
TXMD
TherapeuticsMD Inc
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-3.1
TXMD
TherapeuticsMD Inc
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K/A
EX-3.1
TXMD
TherapeuticsMD Inc
6 Jun 22
Amendments to Articles of Incorporation or Bylaws
6:03am
8-K
EX-3.1
e93c2pqa0cer yovt
3 Jun 22
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-3.1
7f53o0tcgr z426x
9 May 22
Material Modifications to Rights of Security Holders
6:30am
8-K
EX-3.1
6f02 fq35aug0hua
22 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
mdmuclqk863 0uxfv5
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
SC TO-T/A
EX-3
y94eoxc1t1t
18 Jul 05
Third party tender offer statement (amended)
12:00am
- Prev
- 1
- Next